Background and Objective: Ménière's disease (MD) is a disorder of the inner ear typically showing recurrent acute episodes of vertigo, hearing loss, and tinnitus. Epidemiologic studies on MD are scarce. We assessed the incidence rates (IRs) of MD and describe the characteristics of MD cases, comparing them to control patients without recorded evidence of MD. Study Design: We conducted a retrospective population-based follow-up study and a nested case-control analysis using data from the UK-based Clinical Practice Research Datalink. Methods: We identified patients between 18 and 79 years of age with an incident MD diagnosis between January 1993 and December 2014. We assessed the IRs of betahistine-treated MD. In the nested case-control analysis, we matched 4 controls to each MD case on sex, age, general practice, years of active history in the database, and calendar time. We conducted a χ2 test to present p values in order to compare the prevalence of demographics, comorbidities, and co-medication between cases and controls. Results: We identified 5,508 MD cases and 22,032 MD-free controls (65.4% females). The overall IR for MD in the UK was 13.1 per 100,000 person-years. More cases were female, and the mean age at diagnosis was 55.4 ± 13.7 years. Smoking and alcohol consumption were less prevalent among MD cases. Depression, other affective disorders, sleeping disorders, anxiety, and migraine were more prevalent among MD cases than among controls. Conclusions: MD is uncommon in primary care in the UK with a preponderance among females.

Keywords:
Ménière’s disease, Clinical Practice Research Datalink, Epidemiology, Nested case-control study
1.
Alexander TH, Harris JP: Current epidemiology of Meniere's syndrome. Otolaryngol Clin North Am 2010;43:965-970.
2.
British National Formulary. www.bnf.org (accessed January 2015).
3.
Coelho DH, Lalwani AK: Medical management of Ménière's disease. Laryngoscope 2008;118:1099-1108.
4.
da Costa SS, de Sousa LCA, de Toledo Piza MR: Meniere's disease: overview, epidemiology, and natural history. Otolaryngol Clin North Am 2002;35:455-495.
5.
Gazquez I, Soto-Varela A, Aran I, Santos S, Batuecas A, Trinidad G, et al: High prevalence of systemic autoimmune diseases in patients with Menière's disease. PLoS One 2011;6: e26759.
6.
Harcourt J, Barraclough K, Bronstein AM: Meniere's disease. BMJ 2014;349:g6544.
7.
Herrett E, Gallagher AM, Bhaskaran K, Forbes H, Mathur R, van Staa T, et al: Data resource profile: Clinical Practice Research Datalink (CPRD). Int J Epidemiol 2015;6:827-836.
8.
Herrett E, Thomas SL, Schoonen WM, Smeeth L, Hall AJ: Validation and validity of diagnoses in the General Practice Research Database: a systematic review. Br J Clin Pharmacol 2010;69:4-14.
9.
Hoa M, Friedman RA, Fisher LM, Derebery MJ: Prognostic Implications of and audiometric evidence for hearing fluctuation in Meniere's disease. Laryngoscope 2015;125:1-12.
10.
James A, Thorp M: Ménière's disease. BMJ Clin Evid 2007;3:505.
11.
Jick H: A database worth saving. Lancet 1997;350:1045-1046.
12.
Jick H, Jick SS, Derby LE: Validation of information recorded on general practitioner based computerised data resource in the United Kingdom. BMJ 1991;302:766-768.
13.
Jick H, Jick SS, Derby LE, Terris BZ: Further validation of information recorded on general practitioner based computerised data resource in the United Kingdom. Pharmacoepidemiol Drug Saf 1992;1:347-349.
14.
Jick SS, Kaye JA, Vasilakis-Scaramozza C, Garcia Rodríguez LA, Ruigómez A, Meier CR, et al: Validity of the general practice research database. Pharmacotherapy 2003;23:686-689.
15.
Khan NF, Harrison SE, Rose PW: Validity of diagnostic coding within the General Practice Research Database: a systematic review. Br J Gen Pract 2010;60:e128-e136.
16.
Lopez-Escamez JA, Carey J, Chung W, Goebel JA, Magnusson M, Mandalà M, et al: Diagnostic criteria for Menière's disease. J Vestib Res 2015;25:1-7.
17.
Lopez-Escamez JA, Dlugaiczyk J, Jacobs J, Lempert T, Teggi R, von Brevern M, et al: Accompanying symptoms overlap during attacks in Menière's disease and vestibular migraine. Front Neurol 2014;5:1-5.
18.
Meyerhoff WL, Paparella MM, Shea D: Ménière's disease in children. Laryngoscope 1978;88:1504-1511.
19.
Minor LB, Schessel DA, Carey JP: Ménière's disease. Curr Opin Neurol 2004;17:9-16.
20.
Monsell EM, Balkany TA, Gates GA, Goldenber RA, Meyerhoff WL, House JW: Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in Meniere's disease. Otolaryngol Head Neck Surg 1995;113:181-185.
21.
National Institute for Health and Care Excellence (NICE) Clinical Knowledge Summaries (CKS) Guidelines 2013: Meniere's disease. http://cks.nice.org.uk (UK access only) (accessed January 20, 2015).
22.
Ohmen JD, White CH, Li X, Wang J, Fisher LM, Zhang H, et al: Genetic evidence for an ethnic diversity in the susceptibility to Ménière's disease. Otol Neurotol 2013;34:1336-1341.
23.
Phillips JS, Prinsley PR: Prescribing practices for Betahistine. Br J Clin Pharmacol 2008;65:470-471.
24.
Ray J, Carr SD, Popoli G, Gibson WP: An epidemiological study to investigate the relationship between Meniere's disease and migraine. Clin Otolaryngol 2016;41:707-710.
25.
Requena T, Espinosa-Sanchez JM, Cabrera S, Trinidad G, Soto-Varela A, Santos-Perez P, et al: Familial clustering and genetic heterogeneity in Meniere's disease. Clin Genet 2014;85:245-252.
26.
Saeed SR: Diagnosis and treatment of Ménière's disease. BMJ 1998;316:368-372.
27.
Sajjadi H, Paparella MM: Meniere's disease. Lancet 2008;372:406-414.
28.
Shepard NT: Differentiation of Meniere's disease and migraine-associated dizziness: a review. J Am Acad Audiol 2006;17:69-80.
29.
Stapleton E, Mills R: Clinical diagnosis of Ménière's disease: how useful are the American Academy of Otolaryngology Head and Neck Surgery Committee on Hearing and Equilibrium guidelines? J Laryngol Otol 2008;122:773-779.
30.
Thorp MA, Shehab ZP, Bance ML, Rutka JA: The AAO-HNS Committee on Hearing and Equilibrium Guidelines for the diagnosis and evaluation of therapy in Menière's disease: have they been applied in the published literature of the last decade? Clin Otolaryngol Allied Sci 2003;28:173-176.
31.
Tyrrell J, White MP, Barrett G, Ronan N, Phoenix C, Whinney DJ, et al: Mental health and subjective well-being of individuals with Ménière's: cross-sectional analysis in the UK Biobank. Otol Neurotol 2015;36:854-861.
32.
Tyrrell JS, Whinney DJD, Ukoumunne OC, Fleming LE, Osborne NJ: Prevalence, associated factors, and comorbid conditions for Ménière's disease. Ear Hear 2014;162-169.
33.
Walley T, Mantgani A: The UK General Practice Research Database. Lancet 1997;350:1097-1099.
34.
Weinreich HM, Agrawal Y: The link between allergy and Menière's disease. Curr Opin Otolaryngol Head Neck Surg 2014;22:227-230.
35.
Wladislavosky-Waserman P, Facer GW, Mokri B, Kurland LT: Meniere's disease: a 30-year epidemiologic and clinical study in Rochester, MN, 1951-1980. Laryngoscope 1984;94:1098- 1102.
© 2017 S. Karger AG, Basel
2017
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.